Chabiotech Co.,Ltd.

₩7,290As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:085660Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (5.42%)
Div yield —
ROE (1.80%)
Biotechnology
Beta (5Y) 0.62
PE TTM 623.0
TSR TTM (40.68%)
Mkt cap ₩674.3B
ROIC 24.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,077
10.79%
(23.37%)
Hold 5|3|7|11|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
71.64
72.29
72.36
74.73
22.60%
17.95%
13.83%
7.12%
Revenue₩B
55.62
56.85
55.56
58.30
6.00%
8.25%
1.29%
3.45%
Peers (US$497.2M)
Cap (US$)
PE
447.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.015
(0.330)
(0.320)
EBIT/Intx
1.071
0.197
0.198
Own earn%
13.94
198.21
150.63
Sh yield%
20.91
25.16
25.31
Owners
Insiders/Inst%
12.27
79.22
Short interest%
3.84
SBC / revenue%
2.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
20–24
$1 testx
−0.5
Incr. ROIC%
13